CME BodyGuard BodySet Infusion Sets Recalled for Delivery Inaccuracy
CME America is recalling BodyGuard BodySet infusion sets because they may deliver therapy at inaccurate rates, potentially causing over-infusion or under-infusion.
The agency’s classification
FDA (Devices): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 5/5 (Critical).
Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The recall is classified as FDA Class I, which meets the rubric criteria for a Critical severity score.
Plain-English summary
CME America, LLC is recalling 3,250 units of BodyGuard BodySet infusion administration sets (REF: A120-160SAS). The recall was initiated because the devices may have a delivery inaccuracy ranging from minus 42.8% to plus 17.5%, which exceeds the acceptable limit of plus/minus 13%.
The use of these infusion pump systems could result in the over-infusion or under-infusion of therapy. The affected units were distributed in 48 U.S. states, the District of Columbia, Canada, and the United Kingdom. All lots within the expiry date are included in this recall.
This is an FDA Class I recall. Healthcare facilities and consumers should stop using the affected infusion sets immediately and contact CME America for instructions on return or replacement.
The recalled product
- Product
- BodyGuard BodySet, REF: A120-160SAS
- Manufacturer
- CME America, LLC
- Category
- Medical Device — Infusion Sets
- Affected units
- 3,250
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry date
Distribution
Part of a larger recall action
This product is one of 37 recalled by CME America, LLC under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 37 products in this recall →Related recalls
Same manufacturer · CME America, LLC
See all →- HighCME America T-Syringe Pump Recalled for Motor Wear and Hardware Damage
FDA (Devices) · 2020-12-09
- HighCME America T-Syringe Pump Recalled for Motor Wear and Fluid Damage
FDA (Devices) · 2020-12-09
- HighCME America Recalls Neofeed Syringe Pumps Due to Motor Wear and Cracks
FDA (Devices) · 2020-12-09
- HighCME America T-Syringe Pump T34 Recalled for Motor Wear and Hardware Cracks
FDA (Devices) · 2020-12-09
- SevereCME America Recalls NeoThrive Syringe Pumps Due to Motor Wear
FDA (Devices) · 2020-12-09
Same hazard · delivery inaccuracy
See all →- HighAlung Technologies Recalls Hemolung Respiratory Assist System Infusion Pumps
FDA (Devices) · 2021-02-10
- SevereCME America BodyGuard Microset Infusion Sets Recalled for Delivery Inaccuracy
FDA (Devices) · 2020-07-22
- SevereCME BodyGuard Microset Infusion Sets Recalled for Delivery Inaccuracy
FDA (Devices) · 2020-07-22
- SevereCME America Recalls CMExpress Microbore Sets Due to Delivery Inaccuracy
FDA (Devices) · 2020-07-22
- SevereCME America Recalls CMExpress Microbore Sets Due to Delivery Inaccuracy
FDA (Devices) · 2020-07-22
Similar recalls
- CriticalCME BodyGuard Microset Infusion Sets Recalled for Fluid Under-Delivery
FDA (Devices) · 2020-03-18
- SevereCME America BodyGuard Infusion Pump Systems Recalled for Delivery Inaccuracy
FDA (Devices) · 2020-03-25
- HighCME America Recalls BodyGuard Microset Infusion Sets Due to Filter Defect
FDA (Devices) · 2020-05-13
- SevereCME America Recalls BodyGuard 323 Infusion Pumps for Over-Delivery Risk
FDA (Devices) · 2015-02-25
- HighMedtronic MiniMed Pro-set Infusion Sets Recalled for Insulin Over-delivery Risk
FDA (Devices) · 2017-11-29
- SevereCADD Administration Set recall: medication underdelivery and false alarms
FDA (Devices) · 2023-02-08